Literature DB >> 34402512

Distribution characteristics of drug resistance mutations of HIV CRF01_AE, CRF07_BC and CRF08_BC from patients under ART in Ganzhou, China.

Ying-Na Xie1, Feng-Xiu Zhu2, You-Tian Zhong1, Ya-Ting Chen1, Qian Gao2, Xiao-Ling Lai2, Jun-Jie Liu2, Dan-Dan Huang1, Yu-Ning Zhang1, Xin Chen1.   

Abstract

BACKGROUND: Drug resistance mutation (DRM)-associated virological failure has become a critical issue for ART and the elimination of HIV.
OBJECTIVES: To investigate the distribution characteristics of DRMs of HIV CRF01_AE, CRF07_BC and CRF08_BC, the predominant subtypes in China.
METHODS: Patients receiving ART up to 31 August 2020 in Ganzhou in China were recruited. Full-length sequences of the HIV pol gene were amplified from patients with virological failure. DRMs and antiretroviral susceptibility were explored using the Stanford University HIV Drug Resistance Database HIVdb Program.
RESULTS: Overall, 279 of 2204 patients under ART were found to have virological failure. Nine HIV subtypes were identified among 211 sequences that were amplified successfully and CRF08_BC (37.0%), CRF01_AE (26.1%) and CRF07_BC (25.6%) were the most prevalent, with mutation frequencies of 44.9% (35/78), 52.7% (29/55) and 35.2% (19/54), respectively. The most common DRMs of these three subtypes were K103N and M184V, while the mutation frequencies of M41L, D67N, K70R, K101E, V106M, Y181C, K219E, H221Y and N348I were obviously different among subtypes. The resistance levels and frequencies for antiretroviral drugs for these three subtypes were similar and resistances to nevirapine, efavirenz, lamivudine and emtricitabine were the most frequently observed. Compared with CRF01_AE and CRF07_BC, CRF08_BC had higher proportions of DRMs for NRTIs and lower frequencies of resistance to NRTIs and NNRTIs.
CONCLUSIONS: The distribution characteristics of DRMs of HIV CRF01_AE, CRF07_BC and CRF08_BC were inconsistent and should be considered when selecting antiretroviral strategies, developing new drugs and controlling HIV strains containing DRMs.
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2021        PMID: 34402512     DOI: 10.1093/jac/dkab296

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  2 in total

1.  Impacts of HIV-1 Subtype Diversity on Long-Term Clinical Outcomes in Antiretroviral Therapy in Guangxi, China.

Authors:  He Jiang; Guanghua Lan; Qiuying Zhu; Yi Feng; Shujia Liang; Jianjun Li; Xinjuan Zhou; Mei Lin; Yiming Shao
Journal:  J Acquir Immune Defic Syndr       Date:  2022-04-15       Impact factor: 3.771

2.  Establishment and application of a method of tagged-amplicon deep sequencing for low-abundance drug resistance in HIV-1.

Authors:  Yang Li; Leilei Han; Yanglan Wang; Xiaolin Wang; Lei Jia; Jingyun Li; Jingwan Han; Jin Zhao; Hanping Li; Lin Li
Journal:  Front Microbiol       Date:  2022-08-22       Impact factor: 6.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.